PositoAI
a positivity index
Home Explore Actions Flows Indices News Watchlist Compare PosiDemy Screeners Insights
PosiFunda · Fundamentals

AS ONE Corporation

PosiFunda Ratios Only on PositoAI

PositoAI's own ratios from AS ONE Corporation's yearly results (2023–2026), compared with Healthcare companies in Japan. Tap ? on any ratio for what it means.

Where ¥100 of sales goes

¥88Operating costs¥0.0Interest¥8.3Net profit¥4.2Paid as dividends

Latest year (Mar 2026). Taxes and other income are not shown, so the parts need not add up to 100.

Cash quality

Profit Cash Ratio

¥89

Over the last 3 years, every ¥100 of reported profit came with ¥89 of operating cash.

Lower than 82% of Healthcare companies in Japan.

Self-Funding Ratio

3.6×

Over the last 3 years its own operating cash covered its investment spending (capex) 3.6 times.

Higher than 81% of Healthcare companies in Japan.

Cash Locked Ratio

¥14

For every ¥100 of sales, ¥14 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against ¥12 tied up three years earlier.

More money tied up than 50% of Healthcare companies in Japan.

Growth quality

Steadiness Ratio

3/3 · 2/3

Sales grew in 3 of the last 3 years; profit grew in 2 of 3.

Steadier than 71% of Healthcare companies in Japan.

Growth Efficiency Ratio

¥6

Sales grew 21% in 3 years; of every extra ¥100 of sales, ¥6 became extra profit.

Higher than 50% of Healthcare companies in Japan.

Asset Productivity Ratio

+21% / +5%

In 3 years sales changed by +21% while total assets changed by +5%. Sales grew faster than assets.

Balance-sheet strength

Debt Due Cover Ratio

3.0×

Debt due within a year is covered 3.0 times by its yearly operating cash.

Higher than 76% of Healthcare companies in Japan.

Cash Cushion Ratio

+10%

Cash, after subtracting all debt, equals 10% of its market value (net cash).

Higher than 60% of Healthcare companies in Japan.

Tangible Assets Ratio

98%

Of every ¥100 the company owns, ¥98 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.

More tangible than 61% of Healthcare companies in Japan.

Tangible Net Worth Ratio

98%

Of every ¥100 of net worth, ¥98 is tangible; the rest is goodwill and other intangibles, often from buying other companies.

More tangible than 67% of Healthcare companies in Japan.

Shareholders

Shareholder Slice Ratio

−2%

Share count fell 2% in 3 years (buybacks), so each share's slice of the company became larger. Dividends paid equalled 52% of profit over the same period.

Standard fundamentals

P/E, P/B, ROE, debt, growth and more (14)

AS ONE Corporation owes ¥0.31 for every ¥1 it owns. Net profit rose 12% in the year to Mar 2026, and grew 4% a year on average over 3 years.

Compared with Healthcare companies in Japan · latest annual results Mar 2026.

P/E ratio

19.5

Investors pay ¥19.5 for every ¥1 of AS ONE Corporation's yearly profit, higher than 68% of Healthcare companies in Japan.

P/B ratio

2.61

The share price is 2.61 times AS ONE Corporation's book value per share, higher than 75% of Healthcare companies in Japan.

Market cap

¥186.0 B

The total market value of all of AS ONE Corporation's shares at today's price (share price × number of shares), larger than 81% of Healthcare companies in Japan. PosiCap size class: Meso Cap.

Net worth (book value)

¥71.2 B

What AS ONE Corporation would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (31 Mar 2026).

Book value per share

¥997.96

Net worth divided by the number of shares. The share price of ¥2,608 is 2.6 times this, which is the P/B above.

Return on equity (ROE)

13.9%

AS ONE Corporation earned 13.9% on its shareholders' money over the last year, higher than 80% of Healthcare companies in Japan.

Owes vs Owns

0.31×

AS ONE Corporation owes ¥0.31 for every ¥1 it owns (low), lower than 57% of Healthcare companies in Japan.

Dividend yield

2.53%

AS ONE Corporation pays 2.53% of its share price as dividends a year, lower than 58% of dividend-paying Healthcare companies in Japan.

Revenue growth

+7%

Revenue rose 7% in the year to Mar 2026, and grew 7% a year on average over 3 years.

Profit growth

+12%

Net profit rose 12% in the year to Mar 2026, and grew 4% a year on average over 3 years.

Profit margin

8.3%

AS ONE Corporation keeps ¥8 of every ¥100 of revenue as net profit.

Cash quality

0.7×

Cash from AS ONE Corporation's business was 0.7× its reported profit in the year to Mar 2026 — less cash came in than the profit reported.

Interest cover

347.0×

AS ONE Corporation's operating profit covered its interest costs 347.0 times in the year to Mar 2026.

Cash vs debt

Net cash

AS ONE Corporation held ¥17.4 B more cash than debt (net cash) at Mar 2026.

Questions

What is AS ONE Corporation's P/E ratio?

Investors pay ¥19.5 for every ¥1 of AS ONE Corporation's yearly profit, higher than 68% of Healthcare companies in Japan.

How is P/B calculated on PositoAI?

P/B is market cap divided by net worth from the latest balance sheet. For AS ONE Corporation: ¥186.0 B ÷ ¥71.2 B (31 Mar 2026) = 2.6.

What is AS ONE Corporation's return on equity?

AS ONE Corporation earned 13.9% on its shareholders' money over the last year, higher than 80% of Healthcare companies in Japan.

How much does AS ONE Corporation owe compared with what it owns?

AS ONE Corporation owes ¥0.31 for every ¥1 it owns (low), lower than 57% of Healthcare companies in Japan.

Does AS ONE Corporation pay a dividend?

Yes. AS ONE Corporation pays 2.53% of its share price as dividends a year, lower than 58% of dividend-paying Healthcare companies in Japan.

Is AS ONE Corporation's revenue growing?

Revenue rose 7% in the year to Mar 2026, and grew 7% a year on average over 3 years.

Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.